Search results for: musculoskeletal disease

How Lymphatic Drainage Controls Synovial Inflammation

Michael Cammarata, MD | November 2, 2025

Why do lymphatics fail in inflammatory arthritis? Research from ACR Convergence 2025 points to a network of telocytes & mast cells that control synovial drainage.

Gout & Cardiometabolic Co-Morbidities

Jason Liebowitz, MD, FACR | October 28, 2025

ACR Convergence 2025 experts explore gout’s deep ties to MetS, insulin resistance and cardiovascular mortality, weighing new data on colchicine, febuxostat and SGLT2 inhibitors.

What’s New in Psoriatic Arthritis?

David Pisetsky, MD, PhD | October 28, 2025

Dr. David Pisetsky curated the research presented at ACR Convergence 2025 and answers the question “What new research on psoriatic arthritis has the potential to impact patient care or future research?”

Let’s Discuss: Insights from the ACR Convergence 2025 Review Course

Jason Liebowitz, MD, FACR | October 27, 2025

The Review Course at ACR Convergence 2025 provided a comprehensive update for practitioners. Highlights from the sections on SLE and lupus nephritis, inflammatory brain diseases, drug management of rheumatic diseases and mimics of inflammatory myopathies.

The ACR Names 16 New Masters

Patrice Fusillo | October 25, 2025

The ACR recognizes 16 members with its highest honor. See the 2025 class of ACR Masters & read their personal reflections on this career milestone.

Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis Released

Deborah Levenson | October 8, 2025

New global criteria for pediatric CNO aim to boost research & improve care for this rare autoinflammatory bone disease.

Rheumatology Research Foundation Launches $1 Million Emergency Fund to Safeguard Innovation

From the College | October 5, 2025

In the wake of unprecedented federal research cuts, the new $1 million emergency funding commitment aims to protect vital projects and the future of patient care.

A New Treatment for Fibromyalgia?

Michele B. Kaufman, PharmD, BCGP | September 11, 2025

The FDA has approved a new drug application for TNX-102 SL (Tonmya), a tablet with 2.8 mg of cyclobenzaprine HCl, after two clinical trials demonstrated the safety and effectiveness of the treatment in adults with fibromyalgia.

A Sound Diagnosis for Glandular Swelling

Hung Vo, MD, Zhichun Lu, MD, & Eugene Kissin, MD | August 26, 2025

In this case study, ultrasonography proves useful for excluding a diagnosis of Sjögren’s disease, leading to a correct diagnosis of IgG4-RD.

JAK Inhibitors 101

Jason Liebowitz, MD, FACR | July 28, 2025

Experts provided an in-depth review of Janus kinase (JAK) inhibitors, discussing the latest research on their use in the treatment of specific rheumatic conditions, the risks associated with them and more.